Maternal mortality ratio (per 100 000 live births) - Country reported estimates
Number of reported cases of tuberculosis (DOTS)
Prevalence of smoking any tobacco product among adults (&#8805;15 years) (%)
Percentage of the total population living in cities > 100'000 inhabitants
UV radiation
Density of pharmaceutical personnel (per 10 000 population)
Ambient air pollution in urban areas (Annual PM<sub>10</sub> [&#956;g/m<sup>3</sup>])
Percent of urban inhabitants living in cities covered by PM measurements
Ambient air pollution  attributable deaths per 100'000 children under 5 years
Low-birth-weight newborns (%)
Prevalence of current tobacco use among adolescents (13-15 years) (%)
Total density per million population: Linear Accelerator
Total density per million population: Radiotherapy units
Availability of national list of approved medical devices for procurement or reimbursement
Number of national population surveys -  HIV prevalence
Number of under-five deaths from malaria
Distribution of causes of death among children aged <5 years (%) - Malaria
Distribution of causes of death among children aged <5 years (%) - Injuries
Distribution of causes of death among children aged <5 years (%) - HIV/AIDS
Distribution of causes of death among children aged <5 years (%) - Measles
Distribution of causes of death among children aged <5 years (%) - Pneumonia
Distribution of causes of death among children aged <5 years (%) - Other diseases
Distribution of causes of death among children aged <5 years (%) - Diarrhoea
Distribution of causes of death among children aged <5 years (%) - Prematurity
Distribution of causes of death among children aged <5 years (%) - Neonatal sepsis
Distribution of causes of death among children aged <5 years (%) - Birth asphyxia
Distribution of causes of death among children aged <5 years (%) - Congenital anomalies
Tuberculosis - new and relapse cases
Donor commitments (Million, constant 2009 US$)
Donor disbursements (Million, constant 2009 US$)
Annual incidence of dracunculiasis cases
Net primary school enrolment ratio (%)
Number of reported deaths from cholera
Malaria outpatient cases
Malaria attributed deaths
Daily users of any smokeless tobacco product (crude rate)
Exposure to smoke at home
Exposure to smoke outside home
Representativeness of youth survey
Current smokers of cigarettes (youth rate)
Year of survey of youth
Repeating interval for survey of youth (years)
Access to a toll-free quit line
Smoking cessation support is available in hospitals
Smoking cessation support is available in health clinics or other primary care facilities
Varenicline - legally sold
Varenicline - place available
Fines for violations
Fines on the establishment
Fines on the patron
Number of reported cases of cholera
Cholera case fatality rate
Raised total cholesterol (>= 5.0 mmol/L) (crude estimate)
Mean BMI (kg/m&#xb2;) (crude estimate)
Mean Total Cholesterol (age-standardized estimate)
Mean Total Cholesterol (crude estimate)
Mean fasting blood glucose (mmol/l) (crude estimate)
Mean systolic blood pressure (crude estimate)
Existence of a formal pre-hospital care system
Population
Age-standardized death rates (15+ years), poisoning, per 100,000
Age-standardized death rates (15+ years), violence, per 100,000
Age-standardized death rates, fires, per 100,000
Age-standardized death rates, poisoning, per 100,000
Age-standardized death rates, falls, per 100,000
Age-standardized death rates, violence, per 100,000
National drinking guidelines
Interventions, projects, training
Surveys, research
Production in 1000s hectolitres
Imports in 1000s hectolitres
Exports of wine (grape) in 1000s hectolitres
Sales of wine in 1000s hectolitres
Exports of spirits in 1000s hectolitres
Exports of beer (barley) in 1000s hectolitres
Sales of beer in 1000s hectolitres
Perceived trend in imports
Point prevalence (%), drug use disorders, 15+ years
Data on substance use disorders disseminated in national annual reports
Programmes diverting clients from the justice system towards treatment
Guidelines on the pharmacological treatment of substance use disorders
Sector for inpatient treatment of drug dependence
Financing method for substance use disorder treatment
Governement benefits for persons with substance use disorders
Sector for residential long-term rehabilitation of alcohol use disorders
Sector for residential long-term rehabilitation of drug use disorders
Open access services for substance use disorders
Essential list of medicines, pharmacotherapy for substance use disorders
Pharmacotherapy used for the management of alcohol withdrawal
Commencement of treatment with opioid agonists
Age-standardized death rates, breast cancer, per 100,000
Age-standardized death rates, cerebrovascular disease, per 100,000
Age-standardized death rates, diabetes mellitus, per 100,000
Age-standardized death rates, colon and rectum cancers, per 100,000
Age-standardized death rates, liver cancer, per 100,000
Age-standardized death rates, liver cirrhosis, per 100,000
Age-standardized death rates, oesophagus cancer, per 100,000
Age-standardized death rates, mouth and oropharynx cancer, per 100,000
Age-standardized death rates, prematurity and low birth rate, per 100,000
Age-standardized death rates, self-inflicted injury, per 100,000
Age-standardized DALYs, alcohol use disorders, per 100,000
Age-standardized DALYs, breast cancer, per 100,000
Age-standardized DALYs, cerebrovascular disease, per 100,000
Age-standardized DALYs, colon and rectum cancers, per 100,000
Age-standardized DALYs, diabetes mellitus, per 100,000
Age-standardized DALYs, falls, per 100,000
Age-standardized DALYs, other unintentional injuries, per 100,000
Age-standardized DALYs, poisoning, per 100,000
Age-standardized DALYs, road traffic accidents, per 100,000
Age-standardized DALYs, self-inflicted injury, per 100,000
Age-standardized DALYs, violence, per 100,000
Social costs of alcohol use in millions US$
Groups and agencies for the prevention of substance use disorders
NGOs for drug use disorders
Standards of care for health professionals, maintenance
NGOs for alcohol use disorders
Clinical supervision of health care staff
Psychoactive substance causing entry into treatment
Age-standardized death rates, alcohol and drug use disorders, per 100 000
Age-standardized DALYs, alcohol and drug use disorders, per 100 000
Methadone provision in clinical and community-based settings
Buprenorphine/naloxone provision in clinical and community-based settings
Buprenorphine provision in clinical and community-based settings
Prescription requirements for buprenorphine/naloxone
Supervision requirements for buprenorphine administration
Supervision requirements for buprenorphine/naloxone administration
Harm reduction programmes for IDUs
Programmes for the prevention of substance use disorders for special populations
Funding method for substance use disorder prevention
Buprenorphine/naloxone used for detoxification or maintenance
Timeframe of opioid agonist treatment
Methadone used for detoxification or maintenance
Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance)
Hospital discharges, alcoholic liver disease, per 100,000
Alcohol-related injury mortality, per 1,000
Minimum legal drinking age
Training in screening and brief interventions for alcohol problems
Prevention/counselling at workplaces for those with alcohol problems
Designation of alcohol tax revenues to health services
Interventions/projects actively involving young people and civil society
Community-based interventions/projects involving stakeholders
Population median age (years)
New cases: pulmonary smear-negative
New cases: pulmonary smear unknown/not done
New cases: other
Retreatment cases: treatment after failure (pulmonary smear and/or culture positive)
Retreatment cases: treatment after default (pulmonary smear and/or culture positive)
Retreatment cases: other
Smear-positive tuberculosis treatment-success rate (%)
Government expenditures on mental health as a percentage of total government expenditures on health (%)
Mental health plan
ICT Development Index (IDI)
ICT Development Index (IDI) rank
Importance of measures for enhancing compliance with age limits
New types of alcoholic beverages emerging
Excise tax as a per cent of the retail price of alcoholic beverages
Dracunculiasis certification status of countries at the beginning of the year
Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%)
Procurement of medical devices carried out at the national level
Unit in the Ministry of Health responsible for the management of medical devices
Type of nomenclature system
Use of nomenclature system
Availability of national standards or recommended lists of medical devices
Total density per 100 000 population: Provincial hospitals
Deaths due to HIV/AIDS (per 100 000 population)
Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025
Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol)
Age-standardized DALYs (per 100,000)
Number of physicians
Most recent census (year)
Civil registration coverage of cause-of-death (%)
Distribution of years of life lost by major cause group
Regular reports from national monitoring systems
Legal obligation for schools to include alcohol use prevention
Smear-positive tuberculosis case-detection rate (%)
Ambient air pollution (Annual PM10 [ug/m3])
Household air pollution attributable deaths per 100'000 capita
UV radiation attributable deaths
UV radiation attributable deaths per 100'000 capita
UV radiation attributable DALYs ('000)
UV radiation attributable DALYs per 100'000 capita
Number of dentistry personnel
Dentistry personnel density (per 10 000 population)
Total density per 100 000 population: Specialized hospitals
Total density per million population: Telecobalt Unit
Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging
Number of health warnings approved by the law for other smoked tobacco packaging
Font style, font size and colour of health warnings are mandated for other smoked tobacco packaging
Health warnings on other smoked tobacco packaging must include a photograph or graphic
Smoking cessation support is available in offices of health professionals
Smoking cessation support is available in the community
Bupropion - legally sold
Bupropion - place available
Dedicated funds for enforcement
Citizen complaints and investigations
Raised total cholesterol (>= 5.0 mmol/L) (age-standardized estimate)
Income level
Age-standardized death rates, drownings, per 100,000
Treatment, services
Perceived trend in production
Point prevalence (%), alcohol use disorders, 15+ years
National survey on substance use among children and adolescents
Epidemiological data collection system for substance use disorders
Service delivery data collection system for substance use disorders
Confidentiality of health records on substance use disorders  protected by law
Legislative provision for compulsory treatment
Legislative provision for treatment and rehabilitation of substance use disorders
Budget line for substance use disorder treatment
Length of stay for inpatient long-term residential treatment, days
Length of stay for inpatient short-term treatment, days
Sector for inpatient treatment of alcohol dependence
Sector for outpatient treatment of drug dependence
Sector for inpatient detoxification of drug use disorders
Sector for inpatient detoxification of alcohol use disorders
Government benefits for drug use disorders, subsidy or disability pension
Pharmacotherapy used for the management of benzodiazepine withdrawal
Age-standardized death rates, alcohol use disorders, per 100,000
Age-standardized DALYs, drownings, per 100,000
Age-standardized DALYs, fires, per 100,000
Age-standardized DALYs, liver cancer, per 100,000
Age-standardized DALYs, liver cirrhosis, per 100,000
Age-standardized DALYs, oesophagus cancer, per 100,000
Health professionals mostly involved in treatment of substance use disorders
Prescription requirements for methadone
Supervision requirements for methadone administration
Buprenorphine used for the treatment of opioid dependence
Hospital discharges, alcohol-related injuries and poisoning, per 100,000
Treatment admissions (inpatient), alcoholic psychosis, per 100,000
Alcoholic psychosis, incidence, per 100,000
Public-funded alcohol research/monitoring programmes
Public funds designated for alcohol research/monitoring programmes, in Euros
National treatment policy for alcohol use disorders
National surveys on drink-driving
Counselling to children in families with alcohol problems
Persons with alcohol use disorders receiving treatment (%)
Counselling to pregnant women with alcohol problems
Server training on a regular basis
Consumer information on alcohol and health at points of sale
Brief interventions as health promotion/disease prevention
Educational programmes involving target groups in school curriculum
Human development index rank
Gender inequality index rank
Prices for alcoholic beverages (average, US$)
Community-based interventions involving stakeholders
Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines
National guidelines, policies or recommendations on the procurement of medical devices
Availability of technical specifications of medical devices to support procurement or donations
Data collected on harm from alcohol at workplace
Workplace representatives nationally involved to prevent and address alcohol-related harm
Legal obligation for schools to interact with parents regarding education and well-being
Ambient air pollution attributable deaths
Ambient air pollution  attributable DALYs per 100'000 children under 5 years
Household air pollution  attributable deaths per 100'000 children under 5 years
Household air pollution  attributable DALYs per 100'000 children under 5 years
Civil registration coverage of causes of deaths (%)
Radiotherapy units (per 1 000 000 population)
Nursing and midwifery personnel density (per 10 000 population)
Number of pharmaceutical personnel
Total density per 100 000 population: District/rural hospitals
Types of lists recommending health technology for high burden diseases
Cellular subscribers (per 100 population)
Number of cause-of-death registration years available
Number of national population surveys - child anthropometry
Number of national population surveys - child mortality
International Statistical Classification of Diseases and Related Health Problems (ICD)
Number of national population surveys -  adult health
Preterm birth rate (per 100 live births)
Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging
Specific health warnings are mandated for other smoked tobacco packaging
Health warnings on other smoked tobacco packaging must be rotated
Health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health
Health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country
Smoking cessation support is available in other settings
Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000
Information, education, prevention
Monitoring
Counselling
Perceived trend in sales
Perceived trend in exports
Policy documents on the pharmacological treatment of substance use disorders
Government unit for substance use disorder treatment
Sector for substitution maintenance therapy of opioid dependence
Sector for outpatient treatment of alcohol dependence
Specialized treatment services for drug use disoders and HIV/AIDS
Government benefits for alcohol use disorders, subsidy or disability pension
Essential list of medicines
Age-standardized death rates, ischaemic heart disease, per 100,000
Age-standardized death rates, other unintentional injuries, per 100,000
Age-standardized death rates, road traffic accidents, per 100,000
Age-standardized DALYs, ischaemic heart disease, per 100,000
Age-standardized DALYs, mouth and oropharynx cancer, per 100,000
Age-standardized DALYs, prematurity and low birth rate, per 100,000
Self-help groups for substance use disorders
Standards of care for health professionals
Standards of care for health professionals, human rights
Prescription requirements for buprenorphine
Government unit for substance use disorder prevention
Screening and brief interventions for substance use and substance use disorders
Buprenorphine used for detoxification or maintenance
Buprenorphine/naloxone used for the treatment of opioid dependence
Methadone used for the treatment of opioid dependence
Substance use policy at the national level
Substance use policy at the national level, level of integration
System for monitoring alcohol-related harm
Data collection on alcohol-related health indicators
National alcohol policy specifically involves young people activities
Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average
Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol)
Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Alcohol, tourist consumption (in litres of pure alcohol)
15-19 years old abstainers, lifetime (%)
Data collection on Foetal Alcohol Syndome
Clinical guidelines for brief interventions
Comprehensive and regular reporting of alcohol situation
Distribution of years of life lost by broader causes (%) - Injuries
Number of nursing and midwifery personnel
Adults aged &#8805; 20 years who are obese (%)
Health technology (medical device) national policy
Number of national population surveys - maternal mortality
Men who have sex with men (MSM) with active syphilis (%)
Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging
Health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale
Nicotine replacement therapy - legally sold
Nicotine replacement therapy - place available
Raised total cholesterol (&#8805; 6.2 mmol/L) (crude estimate)
Raised total cholesterol (&#8805; 6.2 mmol/L) (age-standardized estimate)
Gross national income per capita (Atlas method)
Drug courts
Treatment setting for substance use disorders, most common
Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions
Specialized treatment services for substance use disorders and TB
Treatment system for substance use disorders
Prevention activities for substance use disorders, main focus
Budget line for substance use disorder prevention
Methadone formulation used for the treatment of opiod dependence
Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance)
Mental health policy
Percentage of individuals using the Internet
National guidelines for implementing effective community-based interventions
Mobile-cellular telephone subscriptions per 100 inhabitants
Alcohol, patterns of drinking score
Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016
15-19 years old former drinkers (%)
National surveys on heavy espisodic drinking
Number of deaths
15-19 years old total alcohol consumption in litres of pure alcohol
Number of cases of cutaneous leishmaniasis reported
Number of cases of visceral leishmaniasis reported
Extent of implementation of  mental health services for victims of all types of violence
Extent of implementation of child protection services
Gross national income per capita (PPP int. $)
Points of entry
Zoonosis
Food safety
Chemical
Coordination
Surveillance
Response
Preparedness
Prevalence of smoking any tobacco product among persons aged >= 15 years
Prevalence of current tobacco use among adolescents aged 13-15 years
General availability of colon cancer screening at the primary health care level
General availability of ACE inhibitors in the public health sector
General availability of statins in the public health sector
General availability of thiazide diuretics in the public health sector
15-years old any alcoholic beverage consumed in past 30 days, (%)
Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs
Alcohol-related road traffic crashes with fatalities, per 100,000  population
Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities)
Compliance of ban on advertising at point of sale
Compliance of ban on advertising on billboards and outdoor advertising
Compliance with bans on direct advertising
Subnational bans on tobacco advertising, promotion and sponsorship
Ban on display of tobacco products at points of sale
Law requires fines for violations of indirect advertising bans
Ban on advertising: Point of sale
Complete ban on tobacco vending machines
Law requires fines for violations of direct advertising bans
Tax structure: Excise tax proportion of price
Representativeness of survey of adults
Compliance with regulations on smoke-free environments (national legislation)
Compliance of ban on smoking in HEALTH-CARE FACILITIES
Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES
Compliance of ban on smoking in PUBLIC TRANSPORT
Compliance of ban on smoking in PUBS AND BARS
Compliance with bans on promotion and sponsorship
Compliance of ban on promotional discounts
Compliance of ban on non-tobacco goods AND services identified with tobacco brand names
Compliance of ban on brand name of non-tobacco products used for tobacco product
Compliance of ban on appearance of tobacco brands in TV and/or films (product placement)
Compliance of ban on appearance of tobacco products in TV and/or films
Status of bejel endemicity
Child maltreatment: Extent of implementation of home-visiting programmes
Civil registration coverage of births (%)
Antenatal care coverage - at least one visit (%)
Legislation
Radionuclear
Total density per 100 000 population: Hospitals
Contraceptive prevalence (%)
General availability of total cholesterol measurement at the primary health care level
General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level
General availability of urine testing for albumin
General availability of CC blockers in the public health sector
General availability of metformin in the public health sector
Population using solid fuels (%)
Congenital syphilis rate per 100 000 live births
Congenital syphilis number of reported cases
Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol
Population living on <$1 (PPP int. $) a day (%)
Compliance of ban on advertising on national TV and radio
Compliance of ban on advertising on local magazines and newspapers
Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility� activities of the tobacco companies
Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images
Appearance of tobacco products in TV and/or films
Sponsored events
Ban on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activities
Tax administration: Tax stamps applied on tobacco products
Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place
Compliance of ban on smoking in UNIVERSITIES
Compliance of ban on smoking in GOVERNMENT FACILITIES
Compliance of ban on free distribution of tobacco products in the mail or through other means
Compliance of ban on sponsored events
Adult smokeless tobacco use indicator definition
Comprehensive bans in place subnationally
Adult indicator 1 rate
Adult indicator 2 rate
Adult smokeless tobacco use indicator rate
Youth indicator 1 rate
Youth smokeless tobacco use indicator rate
Average - taxes as a % of cigarette price - import duties
Average - taxes as a % of cigarette price - ad valorem excise
Average - taxes as a % of cigarette price - other taxes
Average - taxes as a % of cigarette price - specific excise
Average - taxes as a % of cigarette price - value added tax
Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks)
Prevalence of tuberculosis (per 100 000 population)
Number of prevalent tuberculosis cases
Second-line drug susceptibility testing (DST) available
Laboratories providing tuberculosis diagnostic services using culture (per 5 million population)
Laboratories providing drug susceptibility testing (DST) (per 5 million population)
Total number of notified TB cases
Youth violence: Extent of implementation of life-skills and social development programmes
Elder abuse: Extent of implementation  of caregiver-support programmes
Human resources
General availability of breast cancer screening (by palpation or mammogram) at the primary health care level
General availability of nicotine replacement therapy in the public health sector
General availability of steroid inhalers in the public health sector
Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs
Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets
Existence of operational policy/strategy/action plan for chronic respiratory diseases
Existence of operational policy/strategy/action plan for cardiovascular diseases
Existence of operational policy/strategy/action plan for diabetes
Existence of operational policy/strategy/action plan to reduce physical inactivity
Existence of operational policy/strategy/action plan to decrease tobacco use
Literacy rate among adults aged >= 15 years (%)
Mental hospital admissions (per 100 000 population)
Stand-alone policy or plan for mental health
Adult survey age range
Adult indicator 2 definition
Youth smokeless tobacco use indicator definition
Process evaluation was employed to assess implementation
Compliance of ban on smoking in RESTAURANTS
Tobacco excises increased over the survey period
Average - taxes as a % of cigarette price - total tax
Status of pinta endemicity
Intimate partner violence: Extent of implementation  of dating violence prevention programmes
Extent of implementation of medico-legal services for victims of sexual violence
Risk communication
Laboratory
General availability of cervical cytology at the primary health care level
General availability of peak flow measurement spirometry at the primary health care level
General availability of aspirin (100 mg) in the public health sector
General availability of bronchodilators in the public health sector
General availability of insulin in the public health sector
General availability of oral morphine in the public health sector
Existence of operational policy/strategy/action plan for cancer
Stand-alone law for mental health
Youth survey age range
Youth indicator 1 definition
Adult indicator 1 definition
Name of survey of youth
Tax administration: Bans or limits on duty free imports by travellers
Name of survey of adults
Affordability: Cigarettes are less affordable in 2014 compared to 2008
Compliance of ban on smoking in INDOOR OFFICES
Age-standardized deaths attributable to the environment (per 100 000 population)
Age-standardized DALYs attributable to the environment (per 100 000 population)
Private prepaid plans as a percentage of private expenditure on health
Per capita government expenditure on health at average exchange rate (US$)
Per capita total expenditure on health (PPP int. $)
Per capita government expenditure on health (PPP int. $)
Social security expenditure on health as a percentage of general government expenditure on health
Out-of-pocket expenditure as a percentage of private expenditure on health
Total expenditure on health as a percentage of gross domestic product
Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population)
Deaths attributable to the environment
Disability-adjusted life years (DALYs) attributable to the environment (%)
Children aged <5 years overweight (%)
Children aged <5 years underweight (%)
General government expenditure on health as a percentage of total government expenditure
General government expenditure on health as a percentage of total expenditure on health
Reported number of human rabies deaths
Out-of-pocket expenditure as a percentage of total expenditure on health
Existence of a set of national NCD indicators and has set time-bound national targets for these indicators
Existence of population-based cancer registry
Population living in urban areas (%)
Has a STEPS survey or a comprehensive health examination survey every 5 years
Existence of national screening program for cervical cancer
Type of national cervical cancer screening program
General availability of renal replacement by transplantation in the public health system
General availability of palliative care in primary health care in the public health system
Private expenditure on health as a percentage of total expenditure on health
Per capita total expenditure on health at average exchange rate (US$)
General availability of palliative care in community or home-based care in the public health system
General availability of coronary bypass or stenting in the public health system
General availability of thrombolytic therapy in the public health system
Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate)
Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate)
Mean systolic blood pressure (age-standardized estimate)
Number of licensed qualified anaesthesiologists actively working
Countries that have passed legislation on Universal Health Coverage (UHC)
Magnetic flux density (microT)
Electric field (kV/m)
Power frequency (Hz)
Specific absorption rate (SAR) (W/kg)
Electric field (V/m)
Power density (W/m^2)
Access restrictions
Ministry/office that takes primary responsibility for prevention for substance use
Compulsory treatment for people with drug use disorders in the criminal justice system
Five-year change in government resources for treatment of substance use disorders
Main sector for treatment for drug use disorders
Specialized treatment facilities for drug use disorders
Pharmacotherapy with buprenorphine/naloxone
Registration of medications for opioid dependence
Registration of medications for opioid withdrawal
Registration of naloxone for injection for opioid overdose
Recommendations for screening and brief interventions for substance use in primary health care
Recommendations for screening and brief interventions for substance use in antenatal services
Groups and agencies involved in prevention programs
Prevention programmes for specific populations for alcohol
Ambient air pollution attributable DALYs
Prevention programmes for drugs
Special housing services for alcohol use disorders
Employment services for alcohol use disorders
Employment services for drug use disorders
Open access interventions for drugs
Health professionals providing treatment for alcohol and drug use disorders
Postgraduate training programme in prevention
Continuing professional development in prevention
Educational attainment in treatment
Continuing professional development in treatment
Epidemiological data collection system for substance use among children and adolescents
Treatment programmes for children and adolescents with alcohol use disorders
Standards of care for professionals providing treatment for alcohol and drug use disorders
Educational attainment in prevention
Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders
Voluntary treatment for people with drug use disorders in the criminal justice system
Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders
Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs
Financing methods for treatment for drug use disorders
Prevention programmes for alcohol
Self-help groups
Prevalence of obesity among adults, BMI &GreaterEqual; 30 (age-standardized estimate) (%)
Prevalence of obesity among adults, BMI &GreaterEqual; 30 (crude estimate) (%)
Prevalence of underweight among adults, BMI < 18.5 (age-standardized estimate) (%)
Prevalence of underweight among adults, BMI < 18.5 (crude estimate) (%)
Disability-adjusted life years (DALYs) attributable to the environment
Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors
Existence of any policies to reduce population salt consumption
General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level
Existence of national screening program for breast cancer
Existence of national HPV vaccination programme
General availability of dialysis in the public health system
Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities
General availability of sulphonylurea(s) in the public health sector
Number of imported cases of cutaneous leishmaniasis reported
Number of licensed qualified surgeons actively working
Existence of standards
Restriction and inspection of facilities
Information requirements
Safety requirements
Training requirements
Government unit/official responsible for prevention for substance use
Five years change in international cooperation for treatment of substance use disorders
Confidentiality of people in treatment for substance use disorders
Compulsory treatment for people with alcohol use disorders in the criminal justice system
Financing methods for treatment for alcohol use disorders
Treatment programmes for children and adolescents with drug use disorders
Specialized treatment facilities for substance use disorders
Specialized treatment facilities for alcohol use disorders
Main substance at treatment entry
Pharmacotherapy with methadone
Pharmacotherapy with buprenorphine
Registration of medications for alcohol dependence and withdrawal
Screening and brief intervention for substance use in primary health care
Prevention programmes for specific populations for drugs
HIV, Hepatitis counselling and treatment availability in specialized facilities and services
Programmes readily available
Standards of treatment and care for public specialized treatment facilities
Treatment programmes for women with alcohol use disorders
Open access interventions for alcohol
Service delivery data collection for substance use
System of monitoring alcohol involvement in forensic pathology
Five years change in international cooperation for prevention for substance use
Hypothecated taxes to be spent on prevention and treatment for substance use disorders
Postgraduate training programme in treatment
Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs
Access restrictions to maintenance treatment
Special treatment programmes for gambling disorder
Mean BMI (kg/m&#xb2;) (age-standardized estimate)
Deaths attributable to the environment (%)
Children aged <5 years stunted (%)
Children aged <5 years wasted for age (%)
Existence of a national multisectoral commission, agency or mechanism for NCDs
Implementation of diet and/or physical activity public awareness program
Existence of a diabetes registry
Most widely used screening method in national cervical cancer screening program
General availability of beta blockers in the public health sector
Availability of cardiovascular risk stratification in 50% or more primary health care facilities
Number of imported cases of visceral leishmaniasis reported
Number of licensed qualified obstetricians actively working
Existence of national regulation
Existence of subnational regulation
Ministry/office that takes primary responsibility for treatment of substance use disorders
Voluntary treatment for people with alcohol use disorders in the criminal justice system
Five-year change in government resources for prevention for substance use
Government benefits for people with alcohol use disorders
Government benefits for people with drug use disorders
Guidelines on pharmacological treatment for substance use disorders
Timeframe for maintenance treatment of opioid dependence
Ambient air pollution attributable deaths (per 100 000 population, age-standardized)
Adolescent mortality rate (per 100 000 population)
Screening and brief intervention for substance use in antenatal services
Treatment programmes for women with drug use disorders
Special housing services for drug use disorders
Epidemiological data collection for substance use
Regular reports on epidemiological and service delivery data for substance use
System of monitoring drugs involvement in forensic pathology
Existence of any policies on marketing of foods to children
General availability of diabetes testing (by HbA1c) at the primary health care level
Coverage of national cervical cancer screening program (%)
General availability of retinal photocoagulation in the public health system
Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities
DALYs attributable to ambient air pollution (age-standardized)
Skilled health professionals density (per 10 000 population)
Year of national implementation of regulation
Government unit/official responsible for treatment of substance use disorders
Availability of naloxone
Prevalence of overweight among adults, BMI &GreaterEqual; 25 (age-standardized estimate) (%)
Prevalence of overweight among adults, BMI &GreaterEqual; 25 (crude estimate) (%)
Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (crude estimate) (%)
Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (crude estimate) (%)
Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (crude estimate) (%)
Raised fasting blood glucose (>= 7.0 mmol/L or on medication) (crude estimate)
Raised fasting blood glucose (>=7.0 mmol/L or on medication)(age-standardized estimate)
Identification of other plans in which dementia is integrated (Mental health)
Identification of other plans in which dementia is integrated (Ageing)
Identification of other plans in which dementia is integrated (NCD)
Identification of other plans in which dementia is integrated (Disability)
Inclusion of improved information system as a specific action of the dementia plan
Inclusion of research and innovation as a specific action of the dementia plan
Existence of dementia legislation
Implementation level [national/subnational] of dementia legislation
Presence of formal agreement/joint plan for dementia care coordination
Accessibility of diagnostic services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of diagnostic services in community for dementia [public, private]
Availability of behaviour and psychological management in community for dementia
Accessibility of behaviour and psychological management in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Estimated number of people receiving palliative and end-of-life care services in community for dementia
Availability of social and financial protection for dementia
Accessibility of social and financial protection for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of social and financial protection for dementia [public, private]
Adult day centres
Availability of atleast one adult hygiene products for people with dementia
Majority provider of dementia carer training and education (NGO)
Estimated number of dementia carers receiving training and education
Accessibility of information on legal rights for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of information  on legal rights for dementia carers (Public sector)
Majority provider of information on legal rights for dementia carers (Private sector)
Majority provider of information on legal rights for dementia carers (NGO)
Existence of standards/ guidelines/ protocols for prevention and risk reduction of dementia
Existence of standards/ guidelines/ protocols for diagnosis of dementia
Existence of standards/ guidelines/ protocols for management of dementia
Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia
Data sources used to routinely monitor people with dementia (Other)
Identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease)
Identification of other research plans in which dementia is integrated (NCD)
Implementation level [national/subnational] of research plan in which dementia is integrated
Total number of published dementia research output
Existence of legislation to end discrimination against people with dementia
Existence of legislation to end discrimination against carers of people with dementia
Number of neurologists (per 100,000)
Number of geriatricians or psychogeriatricians (per 100,000)
Density of outpatient social centres (per 100,000 population)
Electronic availability of data sources used to routinely monitor people with dementia
Availability and status of dementia reporting in the past two years
Availability of funding for dementia-specific research plan/programme
Number of nursing personnel
Number of pharmacists
Pharmaceutical personnel density (per 1000 population)
Identification of different sectors in dementia care coordination (Civil society)
Identification of different sectors in dementia care coordination (Private sector)
Identification of different sectors in dementia care coordination (Other)
Implementation level [national/subnational] of dementia care coordination
Existence of dementia-friendly initiative to improve accessibility of public spaces
Existence of dementia-friendly initiative to improve accessibility of public transportation
Existence of dementia-friendly initiative for assistance with home modification
Existence of dementia-friendly initiative with assistive technology for loss of capacity
Existence of dementia-friendly initiative supporting community places for older people
Data sources used to routinely monitor people with dementia (Household surveys)
Data sources used to routinely monitor people with dementia (Administrative data)
Data sources used to routinely monitor people with dementia (Facility survey or records)
Availability of  atleast one assistive technology for people with dementia
Availability of atleast one housing adjustment for people with dementia
Existence of dementia national nongovernmental organization
Majority provider of dementia carer training and education (Public sector)
Majority provider of dementia carer training and education (Private sector)
Reported treatment coverage for substance dependence
Total fertility rate (per woman)
Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%)
Public-private partnerships for eHealth
Proportion of public funding
Government-supported health internet sites provide information in multiple languages
Institutions offer in-service training to health professionals on ICT for health
Public funding for eHealth
Proportion ofpublic private partnerships funding
Tertiary institutions provide students of health sciences with training on eHealth
National  health information system (HIS) policy or strategy
Legal
Priorities
Promoting standards and interoperability
Policy
Strategy includes objectives as to how telehealth contributes to UHC
Lack of evidence that eLearning is effective
Lack of demand for eLearning programmes
Insitutional educational policy does not include eLearning as an approach to teaching health sciences
Lack of suitable courses available
Pre-service eLearning programmes have been evaluated
Country has specific legislation governing the use of national EHR system
which allows individuals electronic access to their own health-related data when held in an EHR
which allows individuals to demand that their own data be corrected  when held in an EHR if it is known to be inaccurate
which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR
Country has  national policy or strategy regulating the use of big data in the health sector
Country has national policy or strategy regulating the use of big data by private companies
Lack of integration between various health services
Births by caesarean section (%)
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol)
Inclusion of dementia in ministry portfolio
Existence of dementia representative in ministry
Inclusion of empowerment as a guiding principle of the dementia plan
Inclusion of multisectoral collaboration as a guiding principles of the dementia plan
Inclusion of universal health coverage as a guiding principle of the dementia plan
Inclusion of dementia-friendly communities as a specific action of the dementia plan
Existence of legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside
Existence of legislation to end coercieve practices for people with dementia
Existence of standards/ guidelines/ protocols for treatment and support of carers and families of people with dementia
Availability of mechanisms to coordinate dementia care across sectors
Identification of different sectors in dementia care coordination  (Health)
Identification of different sectors in dementia care coordination (Social)
Inclusion of basic dementia competencies in training of specialists
Inclusion of basic dementia competencies in training of nurses
Inclusion of basic dementia competencies in training of pharmaceutical personnel
Inclusion of basic dementia competencies in training of social workers
Estimated number of people receiving psychosocial and rehabilitation services in community for dementia
Availability of activities of daily living suppport services in community for dementia
Accessibility of activities of daily living support services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of activities of daily living support services in community for dementia [public, private]
Estimated percentage of hospitals following national dementia standards
Care facilities [long-term care]
Estimated number of people with dementia receiving services at outpatient health centre
Outpatient social centres
Provision of governmental funding to dementia nongovernmental organization for activities/services
Dementia nongovernmental organization's involvement in policy development
Existence of dementia carer support services
Implementation level [national/subnational] of dementia carer support services
Majority provider of psycho-social supports for dementia carers (NGO)
Estimated number of dementia carers receiving psycho-social supports
Existence of respite care for dementia carers
Accessibility of respite care for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of respite care for dementia carers (Public sector)
Majority provider of information on financial benefits/social protection for dementia carers (Private sector)
Majority provider of information on financial benefits/social protection for dementia carers (NGO)
Estimated number of dementia carers receiving financial benefits/social protection
Existence of at least one functioning dementia awareness campaign
Existence of dementia training for first responders
Existence of dementia training for legal professionals
Existence of dementia training for community workers
Existence of dementia training for school children
Availability of routine pharmaceutical records for people with dementia for monitoring purposes
Availability of routine antipsychotic prescription records for people with dementia for monitoring purposes
Existence of a current dementia research plan/programme
Number of people with dementia involved in research routinely monitored
Availability of investigational pharmaceutical trials for dementia
Number of investigational pharmaceutical trials for dementia
Residential long-term care beds (per 10 000 population)
Dementia-specific residential long-term care beds (per 10,000 population)
Density of hospice centres (per 100,000 population)
Hospice centre beds (per 10 000 population)
Dementia-specific hospice care beds (per 10,000 population)
Number of midwifery personnel
Number of dentists
Physicians density (per 1000 population)
Nursing and midwifery personnel density (per 1000 population)
Dentistry personnel density (per 1000 population)
Number of other health workers
Other health workers density (per 1000 population)
Proportion of donor/non public development funding
Donor/ non-public development funding for eHealth
Strategy implementation funding available for eHealth
National eHealth strategy refers to objectives of UHC
strategy refers to the use of ICT to support UHC
Private funding for eHealth
Regulatory oversight of mobile apps for quality, safety and reliability
Funding
Providing oversight and enforcement of data ownership
Enabling access to education where learning facilities are limited
Not possible to gain a health sciences degree entirely through eLearning
Lack of infrastructure
eLearning used for in-service training of health professionals
Improving access to content and experts
eLearning programmes for in-service training of health professionals have been evaluated
Competing educational priorities
Lack of capacity
lack of evidence showing effectiveness of EHR
Lack of evidence showing cost-effectiveness or EHR
Competing health system priorities
Policy or strategy makes specific reference tothe use of social media in the health domain
which allows for the sharing of personal and health data between research entities
to define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth
to protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format
which governs the sharing of digital data between health professionals  in health services in other countries through the use of an EHR
which allows individuals to demand the deletion of health-related data from their EHR
Effective standards and best practices for data capture not fully established
Insufficient incentives for data sharing
Adult mortality rate (probability of dying between 15 and 60 years per 1000 population)
Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized)
Existence of dementia national plan
Targets for monitoring implementation of dementia national plan
Existence of dementia sub-national plan(s)
Inclusion of human rights as a guiding principle of the dementia plan
Inclusion of dementia diagnosis, care and support as a specific action of the dementia plan
Inclusion of support for dementia carers and families as a specific action of the dementia plan
Existence of other laws that apply to the rights of people with dementia
Existence of legislation to file appeals protecting the rights of people with dementia
Existence of dementia standards/ guidelines/ protocols
Implementation level of dementia standards/ guidelines/ protocols (Sub-national)
Existence of standards/ guidelines/ protocols for palliative and end-of-life care for people with dementia
Existence of standards/ guidelines/ protocols of care in hospital for people with dementia
Identification of different sectors in dementia care coordination (Education)
Identification of different sectors in dementia care coordination (Justice)
Availability of dementia care coordination standards/ guidelines/ protocols
Availability of dementia diagnostic rate
Availability of diagnostic services in community for dementia
Majority provider of behaviour and psychological management in community for dementia [public, private]
Availability of psychosocial and rehabilitation services in community for dementia
Majority provider of psychosocial and rehabilitation services in community for dementia [public, private]
Estimated number of people receiving activities of daily living support services in community for dementia
Accessibility of palliative and end-of-life care services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Dementia care facilities [hospitals]
Estimated number of people with dementia living in residential long-term care
Care facilities [hospice centres]
National regulator approval of anti-dementia medication
Availability of at least one anti-dementia medication approved for on-label use reimbursement
Dementia nongovernmental organization equipped with office
Dementia nongovernmental organization office branches (Local)
Dementia nongovernmental organization staff primarily salaried/volunteer
Existence of dedicated resources for dementia carer support services
Existence of dementia carer training and education
Accessibility of psycho-social supports for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]
Majority provider of psycho-social supports for dementia carers (Private sector)
Majority provider of respite care for dementia carers (NGO)
Existence of information on legal rights for dementia carers
Estimated number of dementia carers receiving information on legal rights
Accessibility of financial benefits/social protection for dementia carers [Capital/capital and main cities/capital, main cities, rural areas]
Existence of at least one functioning risk reduction campaign
Availability of dementia-friendly initiatives that improve accessibility
Inclusion of dementia training and education for non-health workers
Existence of dementia training for police and fire services
Existence of dementia training for financial service staff
Routine monitoring of people with dementia
Data used to routinely monitor people with dementia can be disaggregated
Availability of routine outpatient visit records for people with dementia for monitoring purposes
Dementia integrated into other national research plan/programme
Identification of other research plans in which dementia is integrated (Ageing)
Compliance with international health regulations
Availability of funding for dementia national plan
Geriatric-specific hospital beds (per 10,000 population)
Density of residential long-term care facilities (per 100,000 population)
Adult day centre places (per 10,000 population)
Density of outpatient health centres (per 100,000 population)
Total expenditure on dementia research (local currency, self-report)
Total expenditure on dementia clinical/translational research (local currency, self-report)
Estimated population-based prevalence of depression
Population proportion under 15 (%)
National universal health coverage strategy
Infrastructure
Demand
Capacity
Providing guidance on privacy and security
Promoting the development and adoption of mHealth
Country has telehealth policy or strategy
eLearning is used in pre-service education to teach health sciences students
eLearning courses accredited by continuing medical education or professional licensing bodies
Reducing cost of delivering content
Lack of funding
Lack of legislation or regulations covering use of EHR
Country has national EHR
Lack of demand by health professionals and patients
Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice
Country has national policy or strategy on the use of social media by government organizations
to protect the privacy of individuals' health-related  data held in electronic format as an EHR
Research into new analytical methods needs occur to meet the challenges of working with big data
Capacity building required for new skills
Estimated direct deaths from major conflicts (per 100 000 population)
Ill-defined causes in cause-of-death registration (%)
Existence of a set of time-bound national targets based on WHO guidance
Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach
Average of 13 International Health Regulations core capacity scores, 1st version of the questionnaire
Concentrations of fine particulate matter (PM2.5)
Ambient and household air pollution attributable death rate (per 100 000 population)
Dementia integrated into other national plan
Identification of other plans in which dementia is integrated (Other)
Percentage of sub-national regions covered by dementia plan
Inclusion of equity as a guiding principle of the dementia plan
Inclusion of dementia risk reduction as a specific action of the dementia plan
Inclusion of dementia workforce training as a specific action of the dementia plan
Existence of legislation for supported decision making for people with dementia
Existence of legislation to promote community-based services for people with dementia
Implementation level of dementia standards/ guidelines/ protocols (National)
Existence of approved government dementia standards/ guidelines/ protocols
Existence of standards/ guidelines/ protocols for advance care directives, power of attorney or guardianship for people with dementia
Existence of standards/ guidelines/ protocols of care in nursing & residential care facilities for people with dementia
Identification of different sectors in dementia care coordination (Employment)
Identification of different sectors in dementia care coordination (Housing)
Inclusion of basic dementia competencies in training of physicians
Inclusion of basic dementia competencies in training of personal support workers
Existence of community-based health or social care services for dementia
Estimated number of people receiving behaviour and psychological management services in community for dementia
Accessibility of psychosocial and rehabilitation services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas]
Availability of palliative and end-of-life care services in community for dementia
Majority provider of palliative and end-of-life care services in community for dementia [public, private]
Estimated number of people with dementia receiving social and financial protection for dementia
Estimated percentage of residential long-term care facilities following national dementia standards
Outpatient health centres
Estimated number of people with dementia receiving services at outpatient social centre
Availability of generic anti-dementia medication
Dementia nongovernmental organization office branches (Sub-national)
Dementia nongovernmental organization office branches (National only)
Existence of implementation plan for dementia carer support services
Accessibility of dementia carer training and education [Capital/capital and main cities/capital, main cities, rural areas]
Existence of psycho-social supports for dementia carers
Majority provider of psycho-social supports for dementia carers (Public sector)
Majority provider of respite care for dementia carers (Private sector)
Estimated number of dementia carers receiving respite care
Existence of financial benefits/social protection for dementia carers
Majority provider of information  on financial benefits/social protection for dementia carers (Public sector)
Implementation level [national/subnational] of dementia awareness campaign
Implementation level [national/subnational] of dementia risk reduction campaign
Existence of dementia-friendly initiative supporting social opportunities
Existence of dementia training for volunteers
Existence of dementia training for retail and hospitality staff
Data sources used to routinely monitor people with dementia (Clinical records)
Availability of routine hospital admissions records for people with dementia for monitoring purposes
Availability of routine outpatient intervention and treatment records for people with dementia for monitoring purposes
Implementation level [national/subnational] of dementia research plan/programme
Identification of other research plans in which dementia is integrated (Mental health)
Inclusion of dementia in a branch of government [health, ageing, social services, mental health, noncommunicable disease]
Existence of legislation for advanced care directives for people with dementia
Dementia-specific hospital beds (per 10,000 population)
Total dementia hospital admissions (per 100,000)
Density of adult day centres (per 100,000 population)
Dementia-specific adult day centre places (per 10,000 population)
Total expenditure on dementia basic research (local currency, self-report)
Total expenditure on dementia implementation research (local currency, self-report)
Population (in thousands) total
Population proportion over 60 (%)
National eHealth strategy
Proportion of private funding
Regulating mobile devices and software
mHealth programmes are sponsored by government
Effectiveness
Providing incentives and guidance for innovation research and evaluation of health
Government-sponsored mHealth programmes are being evaluated
Cost-effectiveness
Evaluation of any government-sponsored telehealth programmes
Lack of evidence over cost-effectiveness
Lack of national or international standards for interoperability of EHR
National strategy does not promote the adoption of EHR
to address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria
Privacy and security laws need to be in place
Existence of operational policy/strategy/action plan for oral health
Implementation of physical activity public awareness program
Legislative status
Main sector for treatment for alcohol use disorders
Household air pollution attributable deaths
Household air pollution attributable death rate (per 100 000 population)
Household air pollution attributable death rate (per 100 000 population, age-standardized)
Household air pollution attributable DALYs
Household air pollution attributable DALYs (per 100 000 population)
Household air pollution attributable DALYs (per 100 000, age-standardized)
Ambient air pollution attributable deaths in children under 5 years
Household air pollution attributable deaths in children under 5 years
Household air pollution attributable DALYs in children under 5 years
Ambient air pollution attributable death rate (per 100 000 population)
Ambient air pollution attributable death rate (per 100 000 population, age-standardized)
Ambient air pollution attributable DALYs  (per 100 000 population)
Ambient air pollution attributable DALYs  (per 100 000 population, age-standardized)
Ambient air pollution attributable DALYs  in children under 5 years
Number of diarrhoea deaths from inadequate water, sanitation and hygiene
Ambient air pollution attributable YLLs
Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol
Existence of tax on sugar-sweetened beverages
Alcohol, average daily intake in grams among drinkers with 95%CI
Alcohol, total  (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2020 and 2025
Alcohol, abstainers lifetime (%)
Alcohol, consumers past 12 months (%)
Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI
Alcohol-related road traffic crashes, per 100,000 population
Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI
Central coordinating entity for alcohol policy implementation
Framework of national alcohol policy
Advertising restrictions on local radio
Advertising restrictions on national radio
Sectors represented in national alcohol policy
Advertising restrictions on national television
Advertising restrictions on the internet
Advertising restrictions at cinemas
Restrictions on product placement in films/movies
Restrictions on product placement on national television
Restrictions on product placement on cable television
Government support for community action
Penalties for drink driving
Price measures
Off-premise sales restrictions on outlet density
Off-premise sales restrictions on places
On-premise sales restrictions on days
On-premise sales restrictions at specific events
Restrictions on sales promotion from producers (parties, events)
Restrictions on sales promotion from retailers (sales below cost)
Monopoly on exports of alcoholic beverages
Restrictions on sales promotion from owners of pubs and bars (alcohol for free)
Restrictions on sponsorship of sporting events
Restrictions on sponsorship of youth events
Licensing required for exports of alcoholic beverages
Licensing required for imports of alcoholic beverages
Licensing required for wholesale/distribution of alcoholic beverages
Government monopoly on production
Monopoly on wholesale /distribution of alcoholic beverages
Monopoly on imports of alcoholic beverages
Licenses issued for production, change since 2010
Licenses issued for retail sale, change since 2010
Licenses issued for wholesale/distribution, change since 2010
Excise tax on alcoholic beverages
Restrictions on alcohol use in public places
Duty paid or excise stamp on alcohol container
Alcohol content displayed on containers
Number of standard alcoholic drinks displayed on containers
Licence required for retail sales
Awareness activities
Standard drink defined
National surveys on adult alcohol consumption
National system of data collection based on health service delivery
15-19 years old heavy episodic drinkers (population), % with 95%CI
15-19 years old heavy episodic drinkers (drinkers only), %
Heavy episodic drinking (youth 15 -19 years) past 30 days (%)
Alcohol-attributable fractions (15+), road traffic crash deaths (%)
Alcohol-attributable fractions, all-cause deaths (%)
Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%)
Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%)
Age limits on-premise service
Penalties for drink driving, repeated offense
Liver cirrhosis, age-standardized death rates (15+), per 100,000 population
Advertising restrictions on cable television
Advertising restrictions on billboards
Government monopoly on retail sales
Excise duty (average) per hectolitre in Euros
Age limits off-premise sales
Advertising restrictions on social media
Level of taxation adjusted for inflation
Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI
15-19 years old, current drinkers (%)
Server training
National surveys on youth alcohol consumption
Annual revenues from alcohol excise tax in millions US$
Alcohol expenditure as a per cent of total household expenditure
15-years old any alcoholic beverage consumed in past 12 months, (%)
15-years old first drink at 13 years or younger, (%)
15-years old, any alcoholic beverage consumed at least once a week, (%)
Off-premise sales restrictions on days
Off-premise sales restrictions on hours
Existence of a register of patients who had rheumatic fever and rheumatic heart disease
Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease
Number of diarrhoea DALYs from inadequate hygiene
Attributable fraction of diarrhoea to inadequate hygiene
Number of diarrhoea DALYs from inadequate water, sanitation and hygiene
Biomedical engineers density (per 10 000 population)
Biomedical technicians density (per 10 000 population)
Alcohol, former drinkers (%)
Adopted written national policy on alcohol, year adopted
Adopted written national policy on alcohol, year revised
Alcoholic beverage legally defined
Adopted written national policy on alcohol
Advertising restrictions in print media
Advertising restrictions at point-of-sale
Random breath testing (RBT) use
Detection of marketing infringements
Off-premise sales restrictions at petrol stations
On-premise sales restrictions on hours
On-premise sales restrictions to intoxicated persons
Health warning labels on under-age drinking
National guidelines for alcohol problem prevention and counselling at workplaces
National system of epidemiological data collection for alcohol use
Report with data from health services on alcohol use and AUDs
Cancer, age-standardized death rates (15+), per 100,000 population
Road traffic injuries, age-standardized death rates (15+), per 100,000 population
Alcohol, consumption of pure alcohol by type of beverage (%)
National legislation to prevent illegal alcohol sales
Graduated licensing
Number of diarrhoea deaths from inadequate hygiene
Number of biomedical engineers
Action Plan for implementation of alcohol policy
National legislation to prevent illegal alcohol
Sobriety checkpoints
Off-premise sales restrictions at specific events
On-premise sales restrictions on outlet density
On-premise sales restrictions on places
Taxation of ethanol production
Ethanol tax deducted from excise tax
Value-added tax (VAT) on alcohol (%)
Consumer information about calories, additives, etc on containers
Health warning labels on alcohol advertising
Licence required for production
National guidelines for the prevention and reduction of alcohol-related harm in schools
Legislation on alcohol testing at workplaces
National systems for monitoring alcohol consumption and harms
Report with epidemiological data on lcohol use and AUDs
Alcohol-attributable fractions (15+), cancer deaths
Alcohol-attributable fractions (15+), liver cirrhosis deaths (%)
Alcohol-attributable Years of Life Lost (YLL) score
Alcohol use disorders (15+), 12 month prevalence (%) with 95%
Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%)
Distribution of causes of death among children aged < 5 years (%)
Deaths per 1 000 live births
SDG 3.9.2 WASH deaths
Attributable fraction of diarrhoea to inadequate water, sanitation and hygiene
Number of biomedical technicians
Level of adoption of national alcohol policy
Standard drink measures, in grams per unit
Level of enforcement of BAC limits
Penalties for marketing infringements
Tax incentives for production of other alcoholic beverages
Tax incentives for production low/no alcohol content beer
Health warning labels on drink-driving
Health warning labels on pregnancy
Health warning labels on alcohol containers
Legal requirement for size of health warning labels
National organization for monitoring alcohol
Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI
Legal blood alcohol concentration (BAC) limits
Average price 500 mls Beer in US$
Average price 750 mls Wine in US$
Alcoholic excise tax revenue as a per cent of government revenue
Average price 500 mls Spirits in US$
Availability of estimates on impoverishment due to out-of-pocket health expenditures
Availability of estimates on large health expenditures as a share of total expenditure or income
Leprosy - Number of cases registered for treatment
Leprosy - Number of new child (less than 15 years of age) cases
Leprosy - Number of new child (less than 15 years of age) cases detected with G2D
Leprosy - Number of female new cases
Presence of porcine cysticercosis
Leprosy - New leprosy cases with G2D rate per 1 000 000 population
Leprosy - Registered cases per 10 000 population
Participation rate in organized learning (one year before the official primary entry age) (%)
Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%)
Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%)
Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%)
Publication year of the policy or plan (latest revision)
Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%)
Psychiatrists working in mental health sector (per 100 000 population)
Psychologists working in mental health sector (per 100 000 population)
Low birth weight, prevalence (%)
Low birth weight (in thousands)
Population using safely managed drinking-water services (%)
Population using at least basic drinking-water services (%)
Population using safely managed sanitation services (%)
Population using at least basic sanitation services (%)
Population practising open defecation (%)
Proportion of population below the international poverty line of US$1.90 per day (%)
Proportion of ever-partnered women and girls aged 15-49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months
UHC SCI components: Reproductive, maternal, newborn and child health
UHC SCI components:  Infectious diseases
UHC SCI components: Noncommunicable diseases
UHC SCI components: Service capacity and access
Poliomyelitis - number of reported cases
Number of maternal deaths
Leprosy - Number of new G2D cases
Leprosy - New cases detection rate per 100 000 population
Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2)
Completeness of cause-of-death data (%)
Nurses working in mental health sector (per 100 000 population)
Mental health units in general hospitals (per 100 000 population)
Maternal mortality ratio (per 100 000 live births)
Data availability for UHC index of service coverage (ranking)
Households impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities) (%)
Number of new leprosy cases
Prevalence of insufficient physical activity among school going adolescents aged 11-17 (crude estimate)
Population pushed below the $1.90 a day poverty line by household health expenditures (%)
Increase in poverty gap due to household health expenditures at the $1.90 a day poverty line, in cents of international dollars
Population with household expenditures on health greater than 10% of total household expenditure or income (SDG indicator 3.8.2) (%)
Population with household expenditures on health greater than 25% of total household expenditure or income (SDG indicator 3.8.2) (%)
Increase in poverty gap due to household health expenditures, expressed as a proportion of the $1.90 a day poverty line (%)
Population pushed below the $3.20 a day poverty line by household health expenditures (%)
Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.20 a day poverty line (%)
Reporting countries
Proportion of isolates with resistance to azithromycin reported to WHO-GASP
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP
Number of isolates tested for azithromycin
Number of isolates tested for ciprofloxacin
Number of isolates tested for ceftriaxone
Number of isolates tested for extended-spectrum cephalosporins
General availability of bone marrow transplantation in the public health system
Prevalence of current tobacco use among persons aged 15 years and older (age-standardized rate)
Distribution of road traffic deaths by type of road user (%)
Persistence to last grade of primary (% of cohort)
Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI
Antenatal care coverage - at least four visits (%)
Practice of backyard pig production
Average death rate due to natural disasters (per 100 000 population)
Infants exclusively breastfed for the first six months of life (%)
Social workers working in mental health sector (per 100 000 population)
Beds for mental health in general hospitals (per 100 000 population)
Households further impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities) (%)
Increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line (60% of median daily per capita consumption or income) (%)
Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP
Number of isolates tested for cefixime
General availability of Angiotensin II receptor blockers (ARBs) in the public health sector
Formative research was conducted prior to the campaign
Outcome evaluation was employed to assess effectiveness of the campaign
Campaign was part of a comprehensive tobacco control programme
Campaign was pre-tested
Process evaluation was employed to assess implementation of the campaign
Campaign utilized media planning
At least one national mass media campaign ran during the survey period
Earned media/public relations were used to promote the campaign
Campaign ran on both national television and radio
Overall compliance with bans on direct advertising (score)
Overall compliance with bans on promotion and sponsorship (score)
Compliance with ban on appearance of tobacco brands in TV and/or films (score)
Compliance with ban on appearance of tobacco products in TV and/or films (score)
Compliance with ban on free distribution in mail or through other means (score)
Subnational bans on advertising, promotion and sponsorship - at least one jurisdiction has a comprehensive ban in place
Enforce bans on tobacco advertising
Ban on advertising on national television and radio
Ban on promotional discounts
Ban on identifying non-tobacco products with tobacco brand names
Ban on use of brand name of non-tobacco product for tobacco product
Ban on appearance of tobacco brands in TV and/or films (product placement)
Ban on appearance of tobacco products in TV and/or films
Ban on sponsorship (contributions and/or publicity of contributions)
Ban on any form of contribution (financial or other support) to any event, activity or individual
Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals
Ban on Corporate Social Responsibility activities (CSR)
Ban on tobacco companies/the tobacco industry publicizing their CSR activities
Ban on entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industry
Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth
Ban on advertising on international television and radio
Law requires fines for violations of advertising bans
Law requires fines for violations of promotion and sponsorship bans
Subnational bans on tobacco advertising, promotion and sponsorship authority exists
Ban on tobacco vending machines
Ban on internet sales of tobacco products
Ban on advertising in local magazines and newspapers
Ban on advertising in international magazines and newspapers
Ban on billboard and outdoor advertising
Ban on advertising at point of sale
Ban on product display at point of sale
Ban on advertising on the internet
Ban on free distribution in mail or through other means
Monitor
Budget year
Annual budget for tobacco control in currency reported
Government objectives on tobacco control exist
Bupropion - cost covered
Cytisine - cost covered
Status of endemicity of Taenia solium
Number of pigs in the country
Year the law was enacted (latest revision)
Community residential facilities (per 100 000 population)
Beds in community residential facilities (per 100 000 population)
Mental health outpatient facilities (per 100 000 population)
Mental health day treatment facilities (per 100 000 population)
Average of 13 International Health Regulations core capacity scores, SPAR version
Data availability for UHC index of service coverage
Increase in poverty gap due to household health expenditures at the $3.20 a day poverty line, in cents of international dollars
Population pushed below a relative poverty line by household health expenditures (60% of median daily per capita consumption or income) (%)
Estimated number of tests performed where results were received by a person (testing volume), estimated number per 1000 population
Reported number of tests performed where results were received by a person (testing volume), reporting period
ICD-11 implementation progress level
Compliance with ban on advertising on national television and radio (score)
Compliance with ban on indentifying non-tobacco products with tobacco brand names (score)
Compliance with ban on sponsorship (contributions and/or publicity of contributions) (score)
Compliance with ban on advertising at point of sale (score)
National agency for tobacco control exists
Number of full-time equivalent staff in national agency
Cytisine - legally sold
Cytisine - place available
Smoking cessation support is cost-covered in the community
Smoking cessation support is cost-covered in health clinics or other primary care facilities
Smoking cessation support is cost-covered in offices of health professionals
Smoking cessation support is cost-covered in other settings
Nicotine replacement therapy - cost covered
Varenicline - cost covered
Compliance with smoke-free education facilities except universities law (score)
Compliance with smoke-free indoor offices law (score)
Compliance with smoke-free public transport law (score)
Protect from tobacco smoke
Households with out-of-pocket payments greater than 40% of capacity to pay for health care (food, housing and utilities approach - developed by WHO/Europe) (%)
Households pushed below or further below a relative poverty line (reflecting basic needs: food, housing, utilities) by out-of-pocket payments (%)
Reported number of tests performed where results were received by a person (testing volume)
Number of registered vehicles
Existence of national policies on saturated fatty acids
Existence of national policies on trans-fatty acid elimination
National tobacco control budget - currency reported
Offer help to quit tobacco use
Smoking cessation support is cost-covered in hospitals
Nicotine replacement therapy - on the Essential Medicines List
Overall compliance with regulations on smoke-free environments (score)
Compliance with smoke-free universities law (score)
Compliance with smoke-free restaurants law (score)
Subnational smoking bans - at least one jurisdiction has a comprehensive ban in place
Number of places smoke-free (national legislation)
Subnational smoke-free legislation authority exists
Fines for violations of smoke-free laws
Fines on the patrons of establishments for violations of smoke-free laws
Dedicated funds for enforcement of smoke-free laws
Smoke-free education facilities except universities (national legislation)
Smoke-free universities (national legislation)
Smoke-free indoor offices (national legislation)
Smoke-free restaurants (national legislation)
Smoke-free public transport (national legislation)
Smoke-free other indoor public places (national legislation)
Ban on sale of duty-free or excise-free cigarettes
Affordability - category of change since 2008 (more affordable/less affordable/no change)
Affordability - percentage of GDP per capita required to purchase 2000 cigarettes of the most sold brand
Specific tax component automatically adjusted for inflation (or other)
Reported use of earmarked tobacco taxes
Greater reliance on specific tax  in mixed excise regime
Raise taxes on tobacco
Most sold brand of cigarettes - taxes as a % of price - import duties
Most sold brand of cigarettes - taxes as a % of price - total tax
Tobacco tax revenues - currency reported
Tobacco tax revenues - import duties and all other taxes
Tobacco tax revenues - year reported
Warn about the dangers of tobacco
Law mandates that health warnings appear on cigarette packages
Health warnings on cigarette packaging must include a photograph or graphic
Health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale
Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry
Health warnings on cigarette packaging describe the harmful effects of tobacco use on health
Specific health warnings are mandated for cigarette packaging
Number of health warnings approved by the law for cigarette packaging
Health warnings on cigarette packaging law requires or establishes fines for violations
Ban on deceitful terms on cigarette packaging
Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging
Cigarette packaging and labelling must not use descriptors depicting flavours
Cigarette packaging and labelling must display qualitative information on emission yields
Emission yields must be displayed on one or more principle display areas of cigarette packaging
Display of expiry dates is prevented on cigarette packaging
The quit line number must appear on cigarette packaging or labelling
Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging
Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package
Font style, font size and colour of health warnings are mandated for cigarette packaging
Representativeness of most recent survey of adults
Prevalence of daily smokeless tobacco use among adolescents (%)
Prevalence of current e-cigarette use among adolescents (%)
Prevalence of daily e-cigarette use among adolescents (%)
Prevalence of current tobacco use among adults (%)
Prevalence of daily tobacco use among adults (%)
Prevalence of current tobacco smoking among adults (%)
Prevalence of daily tobacco smoking among adults (%)
Prevalence of current cigarette smoking among adults (%)
Prevalence of daily cigarette smoking among adults (%)
Prevalence of current smokeless tobacco use among adults (%)
Prevalence of daily smokeless tobacco use among adults (%)
Prevalence of current e-cigarette use among adults (%)
Prevalence of daily e-cigarette use among adults (%)
Mean fasting blood glucose (mmol/l) (age-standardized estimate)
Compliance with smoke-free health-care facilities law (score)
Compliance with smoke-free pubs and bars law (score)
Smoke-free health-care facilities (national legislation)
Fines on the establishment for violations of smoke-free laws
Citizen complaints and investigations of violations of smoke-free laws
Smoke-free government facilities (national legislation)
Smoke-free pubs, bars and cafés (national legislation)
Most sold brand of cigarettes - taxes as a % of price - ad valorem excise
Tax stamps, fiscal marks, banderole or other types of marking are applied on other tobacco products
Uniform excise tax applied Yes (Uniform), No (Tiered/varying rates)
Most sold brand of cigarettes - taxes as a % of price - other taxes
Most sold brand of cigarettes - taxes as a % of price - specific excise
Tobacco tax revenues - tobacco product types included
Tobacco tax revenues - valued added tax (VAT) and other sales taxes
Health warnings on cigarette packaging must be rotated
Health warnings on cigarette packaging must be written in the principal language(s) of the country
Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps
Anti-tobacco mass media campaigns
Age range of most recent survey of adults
Name of latest adult prevalence survey (nonsmoked)
Representation of latest adult prevalence survey (nonsmoked)
Representativeness of most recent adolescent survey
Age range of most recent adolescent survey
Age range of latest youth prevalence survey (nonsmoked)
Prevalence of daily tobacco use among adolescents (%)
Prevalence of daily tobacco smoking among adolescents (%)
Prevalence of daily cigarette smoking among adolescents (%)
Alcohol, abstainers past 12 months (%)
Institutional Births (birth taken place in a facility) (%)
Blood Alcohol Concentration (BAC) limit for drivers
Applicability of seat-belt law to all occupants
Seat-belt wearing rate (%)
Most sold brand of cigarettes - taxes as a % of price - value added tax
Existence of a national child-restraint law
Availability of funding for national road safety strategy
Vehicle standards
Estimate of daily tobacco smoking prevalence (%) (age-standardized rate)
Estimate of daily cigarette smoking prevalence (%)
Estimate of daily tobacco smoking prevalence (%)
Estimate of daily tobacco use prevalence (%)
Estimate of daily cigarette smoking prevalence (%) (age-standardized rate)
Estimate of daily tobacco use prevalence (%) (age-standardized rate)
Estimate of current tobacco use prevalence (%)
Estimate of current tobacco use prevalence (%) (age-standardized rate)
Estimate of current tobacco smoking prevalence (%) (age-standardized rate)
Estimate of current cigarette smoking prevalence (%) (age-standardized rate)
Estimate of current cigarette smoking prevalence (%)
Estimate of current tobacco smoking prevalence (%)
Law mandates that health warnings appear on other smoked tobacco packages
Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry
Health warnings on other smoked tobacco packaging law requires or establishes fines for violations
Ban on deceitful terms on other smoked tobacco packaging
Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Other smoked tobacco packaging and labelling must not use descriptors depicting flavours
Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Other smoked tobacco packaging and labelling must display qualitative information on emission yields
Emission yields must be displayed on one or more principle display areas of other smoked tobacco packaging
Display of expiry dates is prevented on other smoked tobacco packaging
The quit line number must appear on other smoked tobacco packaging or labelling
Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package
Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps
Law mandates that health warnings appear on smokeless tobacco packages
Health warnings on smokeless tobacco packaging must include a photograph or graphic
Health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale
Health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health
Number of health warnings approved by the law for smokeless tobacco packaging
Ban on sale of smokeless tobacco products
Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging
Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging
Health warnings on smokeless tobacco packaging must be rotated
Display of expiry dates is prevented on smokeless tobacco packaging
Smokeless tobacco packaging and labelling must display qualitative information on emission yields
Smokeless tobacco packaging and labelling must not use descriptors depicting flavours
Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited)
Health warnings on smokeless tobacco packaging law requires or establishes fines for violations
Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale
Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry
The quit line number must appear on smokeless tobacco packaging or labelling
Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps
Ban on deceitful terms on smokeless tobacco packaging
Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark
Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors
Health warnings on smokeless tobacco packaging must be written in the principal language(s) of the country
Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging
Hospital beds (per 10 000 population)
Number of new HIV infections
Estimated number of people (all ages) living with HIV
Reported number of people receiving antiretroviral therapy
Number of deaths due to HIV/AIDS
Number of pregnant women living with HIV who received antiretrovirals (excluding single dose Nevirapine)  for preventing mother-to-child transmission
Estimated percentage of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission
Estimated antiretroviral therapy coverage among children
Reported number of children receiving antiretroviral therapy
Prevalence of HIV among adults aged 15 to 49 (%)
Estimated antiretroviral therapy coverage among people living with HIV (%)
Estimated number of children needing antiretroviral therapy based on WHO methods
Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission based on WHO methods
Most sold brand of cigarettes - currency reported
Most sold brand of cigarettes - price in currency reported
Compliance with ban on promotional discounts (score)
Compliance with ban on use of brand name of non-tobacco product for tobacco product (score)
Compliance with ban on advertising in local magazines and newspapers (score)
Compliance with ban on billboard and outdoor advertising (score)
Compliance with smoke-free government facilities law (score)
Price dispersion: Share of cheapest brand price in premium brand price (%) (the higher the % the smaller the gap)
Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT)
A minimum price policy is implemented
Tobacco tax revenues - total excise (specific and ad valorem)
Tobacco tax revenues - total revenues
Title of most recent survey of adults
Year of latest adult prevalence survey (nonsmoked)
Age range of latest adult prevalence survey (nonsmoked)
Name of latest youth prevalence survey (nonsmoked)
Year of latest youth prevalence survey (nonsmoked)
Prevalence of current tobacco use among adolescents (%)
Prevalence of current tobacco smoking among adolescents (%)
Prevalence of current cigarette smoking among adolescents (%)
Prevalence of current smokeless tobacco use among adolescents (%)
Existence of a national seat-belt law
Attribution of road traffic deaths to alcohol (%)
Existence of a universal access telephone number for pre-hospital care
Specific health warnings are mandated for smokeless tobacco packaging
Font style, font size and colour of health warnings are mandated for smokeless tobacco packaging
Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package
Tax stamps, fiscal marks, banderole or other types of marking are applied on cigarettes
Minimum specific tax applied in ad valorem or mixed excise regime
Type of excise tax applied.
Year of most recent survey of adults
Year of most recent adolescent survey
Title of most recent adolescent survey
Representation of latest youth prevalence survey (nonsmoked)
Existence of national speed limits
Maximum speed limits
Applicability of national motorcycle helmet law to all occupants
Definition of drink-driving by BAC
Existence of a road safety lead agency
Emission yields must be displayed on one or more principle display areas of smokeless tobacco packaging
Cheapest brand of cigarettes - price in currency reported
Premium brand of cigarettes - price in currency reported
Status of yaws endemicity
Measles-containing-vaccine second-dose (MCV2) immunization coverage by the nationally recommended age (%)
Pneumococcal conjugate vaccines (PCV3) immunization coverage among 1-year-olds (%)
Diphtheria tetanus toxoid and pertussis (DTP3) immunization coverage among 1-year-olds (%)
Hepatitis B (HepB3) immunization coverage among 1-year-olds (%)
Hib (Hib3) immunization coverage among 1-year-olds (%)
Polio (Pol3) immunization coverage among 1-year-olds (%)
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)
Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%)
New HIV infections (per 1000 uninfected population)
Number of under-five deaths
Law requires helmet to be fastened
Existence of a national drink-driving law
Existence of a national road safety strategy
Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI
Tuberculosis effective treatment coverage (%)
New child (less than 15 years of age) leprosy cases rate per 1 000 000 population of children
Number of infant deaths
Number of neonatal deaths
Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%)
Infant mortality rate (probability of dying between birth and age 1 per 1000 live births)
Under-five mortality rate (probability of dying by age 5 per 1000 live births)
Neonatal mortality rate (per 1000 live births)
Number of reported cases of poliomyelitis by wild poliovirus (WPV)
Deaths due to tuberculosis among HIV-negative people (per 100 000 population)
Incidence of tuberculosis (per 100 000 population per year)
Tuberculosis treatment coverage
New cases tested for RR-/MDR-TB (%)
Previously treated cases tested for RR-/MDR-TB (%)
Treatment success rate: new TB cases
Treatment success rate: previously treated TB cases
Number of incident tuberculosis cases
Estimated number of MDR/RR-TB incident cases
Incidence of tuberculosis (per 100 000 population) (HIV-positive cases)
Number of incident tuberculosis cases,  (HIV-positive cases)
Number of deaths due to tuberculosis, excluding HIV
TB patients with known HIV status (%)
Tested TB patients HIV-positive (%)
New or unknown treatment history cases: Pulmonary, clinically diagnosed
New cases: extrapulmonary
New or unknown treatment history cases: Pulmonary, bacteriologically confirmed
New cases: Pulmonary, smear-negative/unknown/not done and other new cases
New cases: Pulmonary, smear-positive
Treatment history unknown
Previously treated  cases, excluding relapse
Relapse cases (pre-2013 definition)
Relapse cases: Pulmonary, clinically diagnosed
Relapse cases: extrapulmonary
Relapse cases: Pulmonary, bacteriologically confirmed
Confirmed cases of RR-/MDR-TB
Stillbirth rate (per 1000 total births)
UHC index of service coverage (SCI)
Diphtheria - number of reported cases
Pertussis - number of reported cases
Total tetanus - number of reported cases
Yellow fever - number of reported cases
Mumps - number of reported cases
Congenital Rubella Syndrome - number of reported cases
Neonatal tetanus - number of reported cases
Total rubella - number of reported cases
Measles - number of reported cases
Zoonotic Events and the Human-animal Interface
Number of incident tuberculosis cases in children aged 0 - 14
Japanese encephalitis - number of reported cases
Legislation and Financing
IHR Coordination and National IHR Focal Point Functions
Food Safety
Risk Communication
Chemical Events
Radiation Emergencies
Healthy life expectancy (HALE) at age 60 (years)
Life expectancy at birth (years)
Healthy life expectancy (HALE) at birth (years)
Life expectancy at age 60 (years)
nMx - age-specific death rate between ages x and x+n
Cases started on MDR-TB treatment
Human Resources
National Health Emergency Framework
Health Service Provision
Points of Entry
ndx - number of people dying between ages x and x+n
nqx - probability of dying between ages x and x+n
lx - number of people left alive at age x
nLx - person-years lived between ages x and x+n
Tx - person-years lived above age x
ex - expectation of life at age x
Population with primary reliance on clean fuels and technologies for cooking (in millions)
Proportion of population with primary reliance on clean fuels and technologies for cooking (%)
Population with primary reliance on polluting fuels and technologies for cooking (in millions)
Proportion of population with primary reliance on polluting fuels and technologies for cooking (%)
Current health expenditure (CHE) per capita in PPP int$
Current health expenditure (CHE) per capita in US$
Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%)
External health expenditure (EXT) per capita in PPP int$
External health expenditure (EXT) per capita in US$
External health expenditure (EXT) as percentage of current health expenditure (CHE) (%)
Domestic general government health expenditure (GGHE-D) per capita in PPP int$
Domestic general government health expenditure (GGHE-D) per capita in US$
Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%)
Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%)
Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%)
Out-of-pocket expenditure (OOP) per capita in PPP int$
Out-of-pocket expenditure (OOP) per capita in US$
Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%)
Domestic private health expenditure (PVT-D) per capita in PPP int$
Domestic private health expenditure (PVT-D) per capita in US$
Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%)
Existence of any national radon activity
National radon concentration levels
Existence of national radon map
Existence of national radon action plan - Years covered
Existence of national reference level for dwellings
Existence of national reference level for buildings with high public occupancy
Radon concentration measurements for new buildings
Radon concentration measurements for existing buildings
Authorization required for prevention/mitigation service providers
Existence of training for mitigation providers
Inclusion of radon in different national strategies
Age-standardized suicide rates (per 100 000 population)
Total NCD Deaths (in thousands)
Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease
Status of endemicity of cutaneous leishmaniasis
Status of endemicity of visceral leishmaniasis
Existence of national radon database
Data in national radon database
Reference level for buildings with high public occupancy (Bq/m3)
Existence of national reference level for workplaces
Reference level for workplaces (Bq/m3)
Existence of official protocols for radon measurements
Existence of national radon risk communication strategy
Inclusion of radon measurements in property transactions
Estimated number of road traffic deaths
Estimated road traffic death rate (per 100 000 population)
Number of deaths attributed to non-communicable diseases, by type of disease and sex
Financial support provided for mitigation (existing dwellings)
Mandatory mitigation measures if legal value is exceeded (existing buildings)
Mandatory preventive measures (new buildings)
Authorization/accreditation required for official radon measurement providers
Radon concentration measurements for workplaces
Radon in building regulations for existing buildings i.e. renovation/remodeling/major alteration
Radon in building regulations for new buildings
Existence of national radon regulations
Mortality rate attributed to unintentional poisoning (per 100 000 population)
Crude suicide rates (per 100 000 population)
Estimates of number of homicides
Estimates of rates of homicides per 100 000 population
Age-standardized NCD mortality rate  (per 100 000 population)
Generalist medical practitioners (number)
Nursing and midwifery personnel  (number)
Medical doctors (number)
Medical doctors not further defined (number)
Specialist medical practitioners (number)
Nursing personnel (number)
Midwifery personnel (number)
Dentists (number)
Existence of any subnational radon activity
Existence of national radon action plan
Radon in national drinking-water regulations
Reference level for dwellings (Bq/m3)
Official standards/guidelines for prevention/mitigation
Inclusion of radon education for building professionals
Physiotherapists (number)
Pharmacists (number)
Nursing and midwifery personnel (per 10 000 population)
Medical doctors (per 10 000 population)
Dentists (per 10 000 population)
Medical doctors (%)
Pharmacists  (per 10 000 population)
NLIS: Population using improved sanitation facility (%)
Population below the international poverty line (%)
Nutrition Governance score
Maternity protection: Compliance with international labour standards
GDP per capita annual growth rate (%)
Reported number of people requiring interventions against NTDs
Women of reproductive age (15−49 years) who are married or in-union who have their need for family planning satisfied with modern methods (%), UNPD
Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths (%)
Births attended by skilled health personnel (%)
Adolescent birth rate (per 1000 women aged 15-19 years)
International Code on Marketing of Breast-milk Substitutes: Legal status of the Code
Girls aged 15 years old that received the recommended doses of HPV vaccine (%)
Prevalence of anaemia in children aged 6–59 months (%)
Number of children aged 6–59 months with anaemia (thousands)
Number of women of reproductive age (aged 15-49 years) with anaemia (thousands)
Number of non-pregnant women (aged 15-49 years) with anaemia (thousands)
Number of pregnant women (aged 15-49 years) with anaemia (thousands)
Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2)
Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N)
Prevalence of anaemia in pregnant women (aged 15-49) (%)
Prevalence of anaemia in non-pregnant women (aged 15-49) (%)
Prevalence of anaemia in women of reproductive age (aged 15-49) (%)
Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years)
Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in their lifetime
Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months
Legally-binding controls on lead paint
NLIS: Population using improved drinking-water sources (%)
Births in baby-friendly facilities (%)
Status of elimination of trachoma as a public health problem
